扶桑薬品工業JP:4538損益計算書

時価総額
¥223.9億
PER
8.8倍
医療用医薬品や医療用機械器具の製造・販売、製造受託、輸液や透析剤の提供、不動産賃貸を手がける企業。
2012/032013/032014/032015/032016/032017/032018/032019/032020/032021/032022/032023/032024/032025/03
売上高44,32048,58149,09847,04245,75246,78245,90046,07446,90249,25149,63251,01555,40760,563
売上原価---34,04633,20233,53232,63032,64434,10135,14236,23537,27541,56844,030
売上総利益---12,99512,55013,24913,26913,42912,80114,10913,39713,74013,83816,532
売上総利益率(%)---
営業利益---7962966567981,2611,0102,3511,9242,2061,9644,131
営業費用---12,19912,25412,59312,47112,16811,79011,76011,47311,53311,87412,401
経常(税引前)利益743,7472,7416781726428321,2791,0662,2271,9962,2151,8683,780
法人税等合計---311107200391361335737427599389-1,682
純利益2664,8711,979340108619708947071,6071,4831,6051,377-3,288
一株あたり利益2.9453.8121.873.770.1195.86109.61101.9680.59183.18169.09183.07159.98-384.95
一株あたり配当金68888448080606060707082